Your browser doesn't support javascript.
loading
Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma.
Gholamin, Sharareh; Youssef, Osama A; Rafat, Marjan; Esparza, Rogelio; Kahn, Suzana; Shahin, Maryam; Giaccia, Amato J; Graves, Edward E; Weissman, Irving; Mitra, Siddhartha; Cheshier, Samuel H.
Afiliação
  • Gholamin S; Division of Pediatric Neurosurgery, Department of Neurosurgery, Lucile Packard Children's Hospital, Stanford University School of Medicine, USA.
  • Youssef OA; Institute for Stem Cell Biology and Regenerative Medicine and the Stanford Ludwig Cancer Center, Stanford University School of Medicine, USA.
  • Rafat M; Division of Pediatric Neurosurgery, Department of Neurosurgery, Huntsman Cancer Institute, School of Medicine, University of Utah, USA.
  • Esparza R; Department of Radiation Oncology, Stanford University, USA.
  • Kahn S; Division of Pediatric Neurosurgery, Department of Neurosurgery, Lucile Packard Children's Hospital, Stanford University School of Medicine, USA.
  • Shahin M; Division of Pediatric Neurosurgery, Department of Neurosurgery, Lucile Packard Children's Hospital, Stanford University School of Medicine, USA.
  • Giaccia AJ; Institute for Stem Cell Biology and Regenerative Medicine and the Stanford Ludwig Cancer Center, Stanford University School of Medicine, USA.
  • Graves EE; Department of Radiation Oncology, Stanford University, USA.
  • Weissman I; Department of Radiation Oncology, Stanford University, USA.
  • Mitra S; Department of Radiation Oncology, Stanford University, USA.
  • Cheshier SH; Institute for Stem Cell Biology and Regenerative Medicine and the Stanford Ludwig Cancer Center, Stanford University School of Medicine, USA.
Innate Immun ; 26(2): 130-137, 2020 02.
Article em En | MEDLINE | ID: mdl-31547758

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Antineoplásicos Alquilantes / Antígeno CD47 / Temozolomida Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Antineoplásicos Alquilantes / Antígeno CD47 / Temozolomida Idioma: En Ano de publicação: 2020 Tipo de documento: Article